Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fed Conditions [Phase 1]
Phase 1 study assessing the relative bioavailability of cetirizine hydrochloride/pseudoephedrine hydrochloride extended-release tablets unde…
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: To Demonstrate the Relative Bioavailability Study of Promethazine HCl 50 mg Tablets Under Fasting Conditions [Phase 1]
Phase 1 study designed to demonstrate the relative bioavailability of Promethazine HCl 50 mg tablets under fasting conditions.
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fasting Conditions [Phase 1]
Phase 1 study to assess the relative bioavailability of cetirizine hydrochloride/pseudoephedrine hydrochloride extended-release tablets unde…
-
CLINICAL_TRIALS trial_result · 2017-03-15Clinical Trial Update: Follow-up Study to Investigate the Effect of GSK2245035 on Nasal Allergic Reactivity in Subjects Completing Treatment in Study TL7116958 [Phase 2]
Follow-up Phase 2 trial assessing the effect of GSK2245035 on nasal allergic reactivity in subjects completing treatment in a prior study; r…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607) [Phase 3]
Phase 3 trial update for SCH 900237/MK-8237 in children and adults with perennial and nonseasonal allergic rhinitis/rhinoconjunctivitis; stu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: A Study of Tolerability and Safety of Two New Doses of Grass MATA MPL [Phase 1]
Phase 1 trial evaluating tolerability and safety of two new doses of Grass MATA MPL for allergic rhinitis has been completed.
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: An Exploratory Study of the Effects of a Single Dose of QAX576 (an Interleukin-13 Monoclonal Antibody) on Simulated Hayfever [Phase 2]
A Phase 2 exploratory trial evaluated a single dose of QAX576, an interleukin-13 monoclonal antibody, for effects on simulated hayfever in a…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: A Cross Over Study to Compare the Effect of Combined Treatment With QAV680 and Cetirizine [Phase 2]
A Phase 2 crossover trial evaluating the combination of QAV680 and cetirizine for allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-13Clinical Trial Update: A Dose-Ranging Study of the Safety and Effectiveness of MK-8237 in the Treatment of House Dust Mite (HDM) Induced Allergic Rhinitis/Rhinoconjunctivitis in Adults (MK-8237-003/P07627) [Phase 2]
Phase 2 dose-ranging study evaluating the safety and effectiveness of MK-8237 for house dust mite–induced allergic rhinitis/rhinoconjunctivi…
-
CLINICAL_TRIALS trial_result · 2017-02-13Clinical Trial Update: Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008) [Phase 1]
Phase 1 safety study of MK-8237 in adolescents with house-dust-mite allergic rhinitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-02-13Clinical Trial Update: MK-8237 (SCH900237) Biomarker Study in Participants With Allergic Rhinitis or Rhinoconjunctivitis (MK-8237-009) [Phase 1]
A Phase 1 biomarker study of MK-8237 (SCH900237) in participants with allergic rhinitis or rhinoconjunctivitis has completed with results po…
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Cellulose Powder Against Grass Pollen Allergic Rhinitis [Phase 2, Phase 3]
Update on Phase 2 and Phase 3 trials evaluating cellulose powder for grass pollen-induced allergic rhinitis, conducted by Nasaleze Internati…
-
CLINICAL_TRIALS trial_result · 2017-01-30Clinical Trial Update: A Study to Investigate the Safety and Pharmacodynamics of Repeat Intranasal Administration of the TLR7 Agonist GSK2245035 in Subjects With Respiratory Allergies [Phase 2]
A phase 2 study evaluating the safety and pharmacodynamics of repeat intranasal dosing of the TLR7 agonist GSK2245035 in subjects with asthm…
-
CLINICAL_TRIALS trial_result · 2017-01-24Clinical Trial Update: Safety and Tolerability of XmAb®7195 in Adult Healthy Volunteers and Adult Subjects With a History of Allergic Rhinitis and/or Allergic Conjunctivitis and/or Atopic Dermatitis [Phase 1]
A Phase 1 study evaluated the safety and tolerability of XmAb7195 in healthy adults and adults with allergic rhinitis, allergic conjunctivit…
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: Effect of Different Pre-seasonal BM32 Dosings on the Induction of a Protective Immune Response [Phase 2]
Phase 2 trial evaluating different pre-seasonal BM32 dosing regimens to induce a protective immune response. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: A Dose-response Evaluation of the SQ Tree SLIT-tablet Using an Environmental Exposure Chamber [Phase 2]
A Phase 2 dose-response study evaluating the SQ Tree SLIT-tablet for allergic rhinoconjunctivitis using an environmental exposure chamber; t…
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: Effects of Whole Sprouts on Airway Allergic Inflammation [NA]
A completed clinical trial assessed the effects of whole sprouts on airway allergic inflammation in individuals with allergic rhinitis and a…
-
CLINICAL_TRIALS trial_result · 2017-01-16Clinical Trial Update: Effects of Bilastine on F1 Simulator Driving Performance in Patients Affected by Allergic Rhinitis and/or Urticaria [Phase 4]
Phase 4 trial evaluating bilastine's effect on F1 simulator driving performance in patients with allergic rhinitis and/or urticaria. Results…
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Effects of Hypertonic Saline Solution (NACL 3%+NAHCO3) on Nasal Inflammation in Children With AR. RinASol- Pilot Study [Phase 4]
A Phase 4 pilot trial evaluated the effects of hypertonic saline solution (3% NaCl plus bicarbonate) on nasal inflammation in children with …
-
CLINICAL_TRIALS trial_result · 2016-12-26Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of CKD-342 [Phase 3]
A Phase 3 clinical trial evaluating CKD-342 for perennial allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-05Clinical Trial Update: Safety of Ciclesonide Nasal Spray Administered With Inhaled Fluticasone Dipropionate/Salmeterol in Adults With Perennial Allergic Rhinitis (BY9010/M1-409) [Phase 3]
Phase 3 safety study evaluating the combination of ciclesonide nasal spray with inhaled fluticasone propionate/salmeterol in adults with per…
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: Safety and Effectiveness of Ciclesonide Nasal Spray in Children (6 to 11 Years) With Perennial Allergic Rhinitis (BY9010/M1-403) [Phase 3]
This clinical trial update reports on the safety and effectiveness of ciclesonide nasal spray for treating perennial allergic rhinitis in ch…
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: To Assess the Safety and Efficacy of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-401) [Phase 3]
A Phase 3 trial evaluating ciclesonide nasal spray for seasonal allergic rhinitis (hay fever) has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-30Clinical Trial Update: Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404) [Phase 3]
Phase 3 study update assessing safety and effectiveness of ciclesonide nasal spray for perennial allergic rhinitis over one year; study comp…
-
CLINICAL_TRIALS trial_result · 2016-11-18Clinical Trial Update: A Clinical Trial to Test How Well Two Drugs, QAW039 and Montelukast Work Both Individually and Together, to Target Allergic Rhinitis Using an Environmental Exposure Chamber [Phase 2]
A completed Phase 2 trial evaluated QAW039 (fevipiprant) and montelukast, alone and in combination, for allergic rhinitis using an environme…